These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 32847701)

  • 21. The predictive value of endorectal 3 Tesla multiparametric magnetic resonance imaging for extraprostatic extension in patients with low, intermediate and high risk prostate cancer.
    Somford DM; Hamoen EH; Fütterer JJ; van Basten JP; Hulsbergen-van de Kaa CA; Vreuls W; van Oort IM; Vergunst H; Kiemeney LA; Barentsz JO; Witjes JA
    J Urol; 2013 Nov; 190(5):1728-34. PubMed ID: 23680307
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of Gleason Subtype on Prostate Cancer Detection Using Multiparametric Magnetic Resonance Imaging: Correlation with Final Histopathology.
    Truong M; Hollenberg G; Weinberg E; Messing EM; Miyamoto H; Frye TP
    J Urol; 2017 Aug; 198(2):316-321. PubMed ID: 28163032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of Magnetic Resonance Imaging and Transrectal Ultrasound Informed Prostate Biopsy for Prostate Cancer Diagnosis in Biopsy Naïve Men: A Systematic Review and Meta-Analysis.
    Goldberg H; Ahmad AE; Chandrasekar T; Klotz L; Emberton M; Haider MA; Taneja SS; Arora K; Fleshner N; Finelli A; Perlis N; Tyson MD; Klaassen Z; Wallis CJD
    J Urol; 2020 Jun; 203(6):1085-1093. PubMed ID: 31609177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostate volume measurement by multiparametric magnetic resonance and transrectal ultrasound: comparison with surgical specimen weight.
    Martins T; Mussi TC; Baroni RH
    Einstein (Sao Paulo); 2020; 18():eAO4662. PubMed ID: 32022105
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiparametric magnetic resonance imaging and active surveillance: How to better select insignificant prostate cancer?
    Porpiglia F; Cantiello F; De Luca S; De Pascale A; Manfredi M; Mele F; Bollito E; Cirillo S; Damiano R; Russo F
    Int J Urol; 2016 Sep; 23(9):752-7. PubMed ID: 27277398
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined Whole Body and Multiparametric Prostate Magnetic Resonance Imaging as a 1-Step Approach to the Simultaneous Assessment of Local Recurrence and Metastatic Disease after Radical Prostatectomy.
    Robertson NL; Sala E; Benz M; Landa J; Scardino P; Scher HI; Hricak H; Vargas HA
    J Urol; 2017 Jul; 198(1):65-70. PubMed ID: 28216327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of Gleason 6 prostate cancer in patients with clinically significant prostate cancer on multiparametric magnetic resonance imaging.
    Chaloupka M; Bischoff R; Pfitzinger P; Lellig E; Ledderose S; Buchner A; Schlenker B; Stief C; Clevert DA; Apfelbeck M
    Clin Hemorheol Microcirc; 2019; 73(1):105-111. PubMed ID: 31561351
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical Utility of 4Kscore
    de la Calle CM; Fasulo V; Cowan JE; Lonergan PE; Maggi M; Gadzinski AJ; Yeung RA; Saita A; Cooperberg MR; Shinohara K; Carroll PR; Nguyen HG
    J Urol; 2021 Feb; 205(2):452-460. PubMed ID: 32897802
    [TBL] [Abstract][Full Text] [Related]  

  • 29. There Is No Way to Avoid Systematic Prostate Biopsies in Addition to Multiparametric Magnetic Resonance Imaging Targeted Biopsies.
    Dell'Oglio P; Stabile A; Soligo M; Brembilla G; Esposito A; Gandaglia G; Fossati N; Bravi CA; Dehò F; De Cobelli F; Montorsi F; Karnes RJ; Briganti A
    Eur Urol Oncol; 2020 Feb; 3(1):112-118. PubMed ID: 31411973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathological and 3 Tesla Volumetric Magnetic Resonance Imaging Predictors of Biochemical Recurrence after Robotic Assisted Radical Prostatectomy: Correlation with Whole Mount Histopathology.
    Tan N; Shen L; Khoshnoodi P; Alcalá HE; Yu W; Hsu W; Reiter RE; Lu DY; Raman SS
    J Urol; 2018 May; 199(5):1218-1223. PubMed ID: 29128577
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiparametric magnetic resonance imaging can exclude prostate cancer progression in patients on active surveillance: a retrospective cohort study.
    Ullrich T; Arsov C; Quentin M; Mones F; Westphalen AC; Mally D; Hiester A; Albers P; Antoch G; Schimmöller L
    Eur Radiol; 2020 Nov; 30(11):6042-6051. PubMed ID: 32591887
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Performance of systematic, MRI-targeted biopsies alone or in combination for the prediction of unfavourable disease in MRI-positive low-risk prostate cancer patients eligible for active surveillance.
    Ploussard G; Beauval JB; Lesourd M; Almeras C; Assoun J; Aziza R; Gautier JR; Loison G; Portalez D; Salin A; Tollon C; Soulié M; Malavaud B; Roumiguié M
    World J Urol; 2020 Mar; 38(3):663-671. PubMed ID: 31197523
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeted prostate biopsy using a cognitive fusion of multiparametric magnetic resonance imaging and transrectal ultrasound in patients with previously negative systematic biopsies and non-suspicious digital rectal exam.
    Kuliš T; Zekulić T; Alduk AM; Lušić M; Bulimbašić S; Ferenčak V; Mokos I; Hudolin T; Kaštelan Ž
    Croat Med J; 2020 Feb; 61(1):49-54. PubMed ID: 32118378
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Value of Serial Multiparametric Magnetic Resonance Imaging and Magnetic Resonance Imaging-guided Biopsies in Men with Low-risk Prostate Cancer on Active Surveillance After 1 Yr Follow-up.
    Hamoen EHJ; Hoeks CMA; Somford DM; van Oort IM; Vergunst H; Oddens JR; Smits GA; Bokhorst LP; Witjes JA; Rovers MM; Hulsbergen-van de Kaa CA; Barentsz JO
    Eur Urol Focus; 2019 May; 5(3):407-415. PubMed ID: 29331622
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PI-RADS Version 2 Category on 3 Tesla Multiparametric Prostate Magnetic Resonance Imaging Predicts Oncologic Outcomes in Gleason 3 + 4 Prostate Cancer on Biopsy.
    Faiena I; Salmasi A; Mendhiratta N; Markovic D; Ahuja P; Hsu W; Elashoff DA; Raman SS; Reiter RE
    J Urol; 2019 Jan; 201(1):91-97. PubMed ID: 30142318
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk of Upgrading from Prostate Biopsy to Radical Prostatectomy Pathology-Does Saturation Biopsy of Index Lesion during Multiparametric Magnetic Resonance Imaging-Transrectal Ultrasound Fusion Biopsy Help?
    Calio BP; Sidana A; Sugano D; Gaur S; Maruf M; Jain AL; Merino MJ; Choyke PL; Wood BJ; Pinto PA; Turkbey B
    J Urol; 2018 Apr; 199(4):976-982. PubMed ID: 29154904
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Efficacy of Multiparametric Magnetic Resonance Imaging and Magnetic Resonance Imaging Targeted Biopsy in Risk Classification for Patients with Prostate Cancer on Active Surveillance.
    Recabal P; Assel M; Sjoberg DD; Lee D; Laudone VP; Touijer K; Eastham JA; Vargas HA; Coleman J; Ehdaie B
    J Urol; 2016 Aug; 196(2):374-81. PubMed ID: 26920465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of Magnetic Resonance Imaging Targeted Biopsy in Detection of Prostate Cancer Harboring Adverse Pathological Features of Intraductal Carcinoma and Invasive Cribriform Carcinoma.
    Prendeville S; Gertner M; Maganti M; Pintilie M; Perlis N; Toi A; Evans AJ; Finelli A; van der Kwast TH; Ghai S
    J Urol; 2018 Jul; 200(1):104-113. PubMed ID: 29408568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Comprehensive Analysis of Cribriform Morphology on Magnetic Resonance Imaging/Ultrasound Fusion Biopsy Correlated with Radical Prostatectomy Specimens.
    Truong M; Feng C; Hollenberg G; Weinberg E; Messing EM; Miyamoto H; Frye TP
    J Urol; 2018 Jan; 199(1):106-113. PubMed ID: 28728994
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study.
    Rouvière O; Puech P; Renard-Penna R; Claudon M; Roy C; Mège-Lechevallier F; Decaussin-Petrucci M; Dubreuil-Chambardel M; Magaud L; Remontet L; Ruffion A; Colombel M; Crouzet S; Schott AM; Lemaitre L; Rabilloud M; Grenier N;
    Lancet Oncol; 2019 Jan; 20(1):100-109. PubMed ID: 30470502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.